📰 Abt News
Page 170 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 22, 2023
Western Pacific Wealth Management LP decreased its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 19.5% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,096 shares of the healthcare product maker’s stock after selling 265 shares during the period. Western Pacific Wealth Management […]
April 21, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its price objective lifted by Raymond James from $116.00 to $123.00 in a report published on Thursday, The Fly reports. ABT has been the subject of a number of other research reports. Wolfe Research lowered their target price on Abbott Laboratories from $107.00 to $103.00 and set an […]
April 21, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its target price upped by UBS Group from $117.00 to $130.00 in a research report report published on Thursday, The Fly reports. They currently have a buy rating on the healthcare product maker’s stock. Other research analysts also recently issued reports about the stock. Raymond James lowered their […]
April 21, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its price target cut by Raymond James from $123.00 to $116.00 in a report issued on Monday, Marketbeat.com reports. They currently have an outperform rating on the healthcare product maker’s stock. A number of other brokerages have also recently weighed in on ABT. Sanford C. Bernstein upped their […]
April 21, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) posted its earnings results on Wednesday. The healthcare product maker reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.05, Briefing.com reports. The company had revenue of $9.75 billion for the quarter, compared to the consensus estimate of $9.64 billion. Abbott Laboratories had a return […]
April 21, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) updated its FY 2023 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $4.30-$4.50 for the period, compared to the consensus estimate of $4.39. The company issued revenue guidance of -. Abbott Laboratories also updated its FY23 guidance to $4.30-4.50 EPS. Analyst Upgrades and Downgrades […]
April 21, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its price objective upped by Sanford C. Bernstein from $132.00 to $133.00 in a research note published on Thursday morning, Briefing.com reports. They currently have an outperform rating on the healthcare product maker’s stock. ABT has been the subject of a number of other research reports. Wells Fargo […]
April 21, 2023
Illinois Municipal Retirement Fund lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 8.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 257,236 shares of the healthcare product maker’s stock after selling 22,459 shares during the period. Abbott Laboratories comprises about […]
April 21, 2023
MainStreet Investment Advisors LLC decreased its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 16.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,294 shares of the healthcare product maker’s stock after selling 671 shares during the quarter. MainStreet Investment Advisors […]
April 21, 2023
MainStreet Investment Advisors LLC decreased its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 16.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,294 shares of the healthcare product maker’s stock after selling 671 shares during the quarter. MainStreet Investment Advisors LLC’s holdings […]